Cormorant Asset Management LP 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-16 4:30 pm Sale | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Cormorant Asset Management LP | 1,837,739 14.520% | -57,978 (-3.06%) | Filing |
| 2024-10-11 4:22 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Cormorant Asset Management LP | 1,895,717 14.980% | 1,895,717 (New Position) | Filing |